NCT01177306View on ClinicalTrials.gov

Inuniv and Working Memory

PHASE4CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

May 31, 2014

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

extended release guanfacine

1-4 mg daily. Dose determined by response of ADHD symptoms to drug and by body mass limitations

Trial Locations (1)

27513

3C Family Services, Cary

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Shire

INDUSTRY

lead

Lori A. Schweickert, MD

INDIV